Abstract
One of the key elements in developing a treatment for any disorder is understanding its cause. As simple and logical as that statement sounds, it nevertheless represents the major obstacle to providing effective therapy in most disorders. Indeed, such is the case for the neurological disorder called epilepsy. In part, this can be explained by the fact that epilepsy is not a specific disease, but a family of neurological disorders that is defined by the clinical symptoms displayed by the patient. The plethora of symptoms observed in epilepsy is the result of the seizure process affecting different brain regions. The fact that different areas of the central nervous system can be and are affected suggests a multifactorial cause for this family of seizure disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berridge, M. J., Downes, C. P., and Hanley, M. R.: Lithium amplifies agonist dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J. 206: 587–595, 1982.
Bonhaus, D. W. and Huxtable, R. J.: Seizure-susceptibility and decreased taurine transport in the genetically epileptic rat. Neurochem. Int. 6(3): 365–368, 1984.
Bonhaus, D., Laird, H. E., and Huxtable, R. J.: Decreased taurine transport in epileptic rats. Proc. West. Pharmacol. Soc. 25: 25–28, 1982.
Bonhaus, D. W., Laird, H. E., Mimaki, T., Yamamura, H. I., and Huxtable, R. J.: Possible Bases for the Anti-Convulsant Action of Taurine, In: Sulfur Amino Acids Biochemical and Clinical Aspects (K. Kuriyama, R. J. Huxtable, and H. I. Wata, eds.) Liss, New York, 1983.
Booker, J. G., Jobe, P. C., Dailey, J. W., and Lane, J. D.: Cortical GAB Areceptors in the genetically epilepsy prone rat. Fed. Proc. 42: 365 (abst.), 1983.
Booker, J. G., Dailey, J. W., Jobe, P. C., and Lane, J. D.: Cerebral cortical GABA and benzodiazepine binding sites in genetically seizure prone rats. Life Sci. 1986 (accepted for publication).
Bourn, W. M.: Modulation of audiogenic seizures by cortical norepinephrine in the rat (doctoral dissertation). Tuscon, University of Arizona, 1974.
Bourn, W. M., Chin, L., and Picchioni, A. L.: Enhancement of audiogenic seizure by 6-hydroxydopamine. J. Pharm. Pharmacol. 24: 913–914, 1972.
Bourn, W. M., Chin, L., and Picchioni, A. L.: Effect of neonatal 6-hydroxydopamine treatment on audiogenic seizures. Life Sci. 21: 701–705, 1977.
Bourn, W. M., Chin, L., and Picchioni, A. L.: The role of dopamine in sound-induced convulsions. J. Pharm. Pharmacol. 30: 800–801, 1978.
Bourn, W. M. and Garrett, R. L.: Increased susceptibility of audiogenic rats to barbital withdrawl convulsions. Pharmacol. Biochem. Behav. 19: 839–841, 1983.
Brown, E., Kendall, D. A., and Nahorski, S. R.: Inositol phospholipid hydrolysis in rat cerebral cortical slices: 1. Receptor characterization. J. Neurochem. 42: 1379–1387, 1984.
Browning, R. A., Nelson, D. K., Mogharreban, N., Jobe, P. C., and Laird II, H. E.: Effect of midbrain and pontine tegmental lesions on audiogenic seizures in genetically epilepsy-prone rats. Epilepsia 26(2): 175–183, 1985.
Consroe, P., Kudray, K., and Schmitz, R.: Acute and chronic antiepileptic drug effects in audiogenic seizure-susceptible rats. Exp. Neurol. 70: 626–637, 1980.
Consroe, P. C., Picchioni, A. L., and Chin, L.: Audiogenic seizure susceptible rats. Fed. Proc. 38: 2411–2416, 1979.
Croucher, M. J., Collins, J. F., and Meldrum, B. S.: Anticonvulsant action of excitatory amino acid antagonists. Science 21: 899–901, 1982.
Dailey, J. W. and Jobe, P. C.: Noradrenergic abnormalities in the genetically epilepsy-prone rat: Do they cause or result from seizures? Soc. Neurosci. 9(1): 400, 1983.
Dailey, J. W. and Jobe, P. C.: Anticonvulsant drugs and the genetically epilepsy-prone rat. Fed. Proc. 44: 2640–2644, 1985.
Dailey, J. W., Battarbee, H. D., and Jobe, P. C.: Enzyme activities in the central nervous system of the epilepsy-prone rat. Brain Res. 231: 225–230, 1982.
Dailey, J. W., Reigel, C. E., Jr., Ko, K. H., Acurio, M. T., Penny, J. E., and Jobe, P. C.: Abnormalities in brain norepinephrine levels in genetically epilepsy-prone rats. Soc. Neurosci. (Absts.), 11: 1316, 1985a.
Dailey, J. W., Reigel, C. E., Jr., Woods, T. W., Penny, J. E., and Jobe, P. C.: Types of serotonergic abnormalities characteristic of genetically epilepsy-prone rats (GEPRs). Fed. Proc. 44: 1107, 1985b.
DeFeudis, F. V.: Central glycine-receptors. Gen. Pharmacol. 9: 139–144, 1978.
Duplisse, B. R.: Mechanism of susceptibility of rats to audiogenic seizure (doctoral dissertation). Tucson, University of Arizona, 1976.
Duplisse, B. R., Picchioni, A. L., Chin, L., and Consroe, P.: Electroshock seizure thresholds: Differences between audiogenic and non-audiogenic rats. J. Int. Res. Commun.1: 9, 1973.
Ebadi, M., Jobe, P. C., and Laird II, H. E.: Variation of pyridoxal phosphate and pyridoxal kinase in brains of genetically epilepsyprone rats. Epilepsia 26: 353–359, 1985.
Emson, P. C.: Biochemical and Metabolic Changes in Epilepsy, In: Taurine and Neurological Disorders (A. Barbeau and R. J. Huxtable, eds.) Raven, New York, 1978.
Gehlback, G. and Faingold, C. L.: Audiogenic seizures and effects of GABA and benzodiazepines on inferior colliculus neurons in the genetically epilepsy prone rat. Neurosci. Abst.10: 569, 1984.
Huxtable, R. J. and Laird II, H. E.: Are amino acid patterns necessarily abnormal in epileptic brains? Studies on the genetically seizuresusceptible rat. Neurosci. Lett. 10: 341–345, 1978.
Huxtable, R. J., Laird, H., Bonhaus, D., and Thies, A. C.: Correlations between amino acid concentrations in brains of seizure-susceptible and seizure-resistant rats. Neurochem. Int. 4(1): 73–78, 1982.
Jobe, P. C.: Relationship of brain metabolism to audiogenic seizure in the rat (doctoral dissertation). Tucson, University of Arizona, 1970.
Jobe, P. C.: Pharmacology of Audiogenic Seizures, In: The Pharmacology of Hearing: Experimental and Clinical Bases(R. D. Brown and E. A. Daigneault, eds.) Wiley, New York, 1981.
Jobe, P. C., Brown, R. D., and Dailey, J. W.: Effect of Ro 4–1284 on audiogenic seizure susceptibility and intensity in epilepsy-prone rats. Life Sci. 28: 2031–2038, 1981.
Jobe, P. C. and Laird II, H. E.: Neurotransmitter abnormalities as determinants of seizure susceptibility and intensity in the genetic models of epilepsy. Biochem. Pharmacol. 30: 3137–3144, 1981.
Jobe, P. C., Laird II, H. E., and Dailey, J. W.: Innate abnormalities in CNS serotonin concentrations in genetically epilepsy-prone rats (GEPRs). Absts. Soc. Neurosci. 9: 399, 1983.
Jobe, P. C., Laird II, H. E., Ko, K. H., Ray, T., and Dailey, J. W.: Abnormalities in monoamine levels in the central nervous system of the genetically epilepsy-prone rat. Epilepsia 23: 359–366, 1982a.
Jobe, P. C., Laird II, H. E., Woods, T. W., and Dailey, J. W.: Noradrenergic abnormalities in two independently developed strains of genetically epilepsy-prone rats. Neurosci. Abst. 8: 1982b.
Jobe, P. C., Picchioni, A. L., and Chin, L.: Role of brain norepinephrine on audiogenic seizure in the rat. . Pharmacol. Exp. Ther. 184: 1–10, 1973a.
Jobe, P. C., Picchioni, A. L., and Chin, L.: Role of brain 5-hydroxytryptamine in audiogenic seizure in the rat. Life Sci.13: 1–13, 1973b.
Jobe, P. C., Ko, K. H., and Dailey, J. W.: Abnormalities in norepinephrine turnover rate in the central nervous system of the genetically epilepsy-prone rat. Brain Res. 290: 357–360, 1984a.
Jobe, P. C., Woods, T. W., and Dailey, J. W.: Catecholamine concentrations in the hippocampus, striatum, and the remaining telencephalon of the genetically epilepsy-prone rat (GEPR). Neuro. Abs. 10: 409, 1984b.
Jobe, P. C., Woods, T. W., Reigel, C. E., and Dailey, J. W.: Biogenic amine concentrations in the hypothalamus of the genetically epilepsy-prone rat (GEPR). Pharmacologist 26(3): 220, 1984c.
Jobe, P. C., Reigel, C. E., Jr., Woods, T. W., Penny, J. E., and Dailey, J. W.: Do noradrenergic deficits in the genetically epilepsy-prone rat (GEPR) correlate with seizure susceptibility or severity? Fed. Proc. 44: 1107, 1985.
Ko, K.: Monoamine transmission in the regulation of seizures in genetically epilepsy-prone rat (doctoral dissertation). Shreveport, Louisiana State University, 1981.
Ko, K., Dailey, J. W., and Jobe, P. C.: Effects of increments in norepinephrine concentrations on seizure intensity in the genetically epilepsyprone rats. J. Pharmacol. Exp. Ther. 222: 662–669, 1982.
Ko, K., Dailey, J. W., and Jobe, P. C.: Seizure intensity changes caused by adrenergic agonists in genetically epilepsy-prone rats (GEPR). Fed. Proc. 42: 364, 1983.
Laird II, H. E.: 5-Hydroxytryptamine as an inhibitory modulator of audiogenic seizures (doctoral dissertation). Tucson, University of Arizona, 1974.
Laird II, H. E.: Abnormal concentrations and turnover rates of norepinephrine and dopamine in brains of genetically seizure-susceptible rats. Epilepsia 24: 107, 1983.
Laird, H. E., Chin, L., and Picchioni, A. L.: Enhancement of audiogenic seizure intensity by p-chloromethamphetamine. Proc. West. Pharmacol. Soc. 17: 46–50, 1974.
Laird, H. E., Dailey, J. W., and Jobe, P. C.: Innate abnormalities in norepinephrine levels in genetically epilepsy-prone rats (GEPRs). Fed. Proc. 42: 363, 1983.
Laird II, H. E., Dailey, J. W., and Jobe, P. C.: Neurotransmitter abnormalities in genetically epileptic rodents. Fed. Proc. 43: 2505–2509, 1984.
Laird II, H. E., Hadjicostantinou, M., and Neff, N. H.: Abnormalities in the central cholinergic transmitter system of the genetically epilepsy prone rat. Life Sci. 39(9): 783–787, 1986.
Laird II, H. E. and Huxtable, R. J.: Effect of Taurine on Audiogenic Seizure Response in Rats, In: Taurine (R. Huxtable and A. Barbeau, eds.) Raven, New York, 1976.
Laird, H. E. and Huxtable, R.: Taurine and Audiogenic Epilepsy, In: Taurine and Neurological Disorders (A. Barbeau and R. J. Huxtable, eds.) Raven, New York, 1978.
Lazarewicz, J. W., Noremberg, K., Lehmann, A., and Hamburger, A.: Effects of taurine on calcium binding and accumulation in rabbit hippocampal and cortical synaptosomes. Neurochem. Int. 7(8): 421–427, 1985.
Lehman, A.: Psychopharmacology of the Response to Noise, With Special Reference to Audiogenic Seizure in Mice, In: Physiological Effects of Noise (B. L. Welch and A. S. Welsch, eds.) Plenum, New York, 1970.
Lehman, A. and Huxtable, R. J.: (Personal communications), 1985.
McEachron, D. L., Jobe, P. C., Smith, W. K., Schlusselberg, D., Woodward, D. J., and Waterhouse, B. D.: 2-DG uptake patterns in the CNS of genetically epilepsy-prone rats: A computer facilitated analysis. Neurosci. Abst.10: 409, 1984.
Michell, R. H.: Inositol phospholipid and cell surface receptor function. Biochem. Biophys. Acta 415: 81–147, 1975.
Miller, F. P., Cox, R. H., Snodgrass, W. R., and Maickel, R. P.: Comparative effects of p-chlorophenylalanine, p-chloroamphetamine and
p-chloro-N-methylamphetamine on rat brain, norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid. Biochem. Pharmacol. 19: 435–442, 1970.
Mills, S. A., Reigel, C. E., Jobe, P. C. and Savage, D. D.: Increase in the number of hippocampal (3H)-glutamate binding sites in rats inbred for a genetic predisposition to acoustic stimulus induced seizures. Neurosci. Abst. 11: 1315, 1985.
Mimaki, T., Yabuuchi, H., Laird, H., and Yamamura, H. I.: Effects of seizures and antiepileptic drugs on benzodiazepine receptors in rat brain. Ped. Pharmacol. 4: 205–211, 1984.
Nicoletti, F., Barbaccia, M. L., Iadarola, M., Pozzi, O., and Laird II., H. E.: Abnormality of alpha-1 adrenergic receptors in the frontal cortex of epileptic rats. J. Neurochem. 46: 270–273, 1986.
Nishizuka, Y.: Turnover of inositol phospholipids and signal transduction. Science 225: 1365–1370, 1984.
Pfeifer, A. K. and Galambos, E.: The effect of d1-p-chloroamphetamine on the susceptibility to seizures and on the monoamine level in brain and heart of mice and rats. J. Pharm. Pharmacol. 19: 400–402, 1967.
Picchioni, A., Chin, L., Choisser, D., and Breitner, C.: 5-Hydroxytryptamine (5-HT) and norepinephrine (NE): Relationship to audiogenic seizure. Pharmacologist 5: 238, 1963.
Pletscher, A., Da Prada, M., and Burkard, W. P.: The Effect of Substituted Phenylethylamines on the Metabolism of Biogenic Monoamines, In: International Symposium on Amphetamines and Related Compounds, (E. Costa and S. Garattini, eds.) Raven, New York, 1970.
Reigel, C. E., Jobe, P. C., Woods, T. W., and Dailey, J. W.: A GABAergic convulsant profile in the genetically epilepsy-prone rat. Neurosci. Abst.10: 408, 1984.
Reigel, C. E., Jr., Stewart, J. J., Rinaudo, J. W., Dailey, J. W., and Jobe, P. C.: Extraordinary small doses of intracerebroventricular morphine produces tonic extensor convulsions in the genetically epilepsyprone rat. Fed. Proc. 44: 1106, 1985.
Roberts, R. C., Ribak, C. E., Peterson, G. M., and Oertel, W. H.: Increased numbers of GABAergic neurons in the inferior colliculus of the genetically epilepsy-prone rat. Neurosci. Abst. 10: 410, 1984.
Roth, B. L., Nakaki, T., Chuang, D.-M., and Costa, E.: Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover. Neuropharmacol. 23: 12231225, 1984.
Rudzik, A. D. and Johnson, G. A.: Effect of Amphetamine and Amphetamine Analogs on Convulsive Thresholds, In: International Symposium on Amphetamines and Related Compounds (E. Costa and S. Garrattini, eds.) Raven, New York, 1970.
Savage, D. D., Reigel, C. E., and Jobe, P. C.: The development of angular bundle kindled seizures is accelerated in rats with a genetic predisposition to audiogenic seizures. Neurosci. Abst. 10: 1319, 1985.
Sokoloff, L., Reivich, M., Kennedy, C., Desrosiers, M. H., Patlak, C. S., Pettigrew, K. D., Sakurada, O., and Shinohara, M.: The (14-C)deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28: 897–916, 1977.
Speth, R., Laird II, H. E., and Yamamura, H. I.: Unpublished observations, 1979.
Stewart, J. J., Rinaudo, J. D., Reigel, C. E., Jobe, P. C., and Dailey, J. W.: Intracerebroventricular morphine produces convulsions in genetically epilepsy-prone rats. Neurosci. Abst.10: 408, 1984.
Tacke, U. and Braestrup, C.: A study on benzodiazepine receptor binding in audiogenic seizure-susceptible rats. Acta Pharmacol. Toxicol. 55: 252–259, 1984.
Tower, D. A.: GABA and Seizures: Clinical Correlates in Man, In: GABA in Nervous System Function (E. Roberts, T. N. Chase, and D. B. Tower, eds.) Raven, New York, 1976.
Waterhouse, B. D., McEachron, D. L., and Woodward, D. J.: Personal communications, 1985.
Waters, S.: Serotonin receptor binding: Characterization of serotonin-1 receptor subpopulations and determination of the effect of neurotoxic chemicals on ligand binding interaction. (Masters thesis). Tucson, University of Arizona, 1983.
Wood, J. D.: The role of gamma-aminobutyric acid in the mechanism of seizures. Prog. Neurobiol. 5: 77–95, 1975.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer Science+Business Media New York
About this chapter
Cite this chapter
Laird, H.E., Jobe, P.C. (1987). The Genetically Epilepsy-Prone Rat. In: Jobe, P.C., Laird, H.E. (eds) Neurotransmitters and Epilepsy. Contemporary Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-462-7_4
Download citation
DOI: https://doi.org/10.1007/978-1-59259-462-7_4
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-5982-2
Online ISBN: 978-1-59259-462-7
eBook Packages: Springer Book Archive